What are the key takeaways from NTRA's 2024 earnings?

Natera Inc (NTRA) demonstrated strong performance in 2024, with key takeaways from its earnings report: 1. **Revenue Growth**: Natera achieved significant revenue growth, with Q4 2024 revenue amounting to $476 million, marking a 53% year-on-year increase. This growth was notably seen in the previous quarter, with Q3 2024 recording a 64% increase to $439.8 million. 2. **Gross Margin Improvement**: The company's gross margin improved to 63% in Q4 2024, up from 51% in the previous year. This indicates enhanced operational efficiency and profitability. 3. **Cash Flow Strength**: Natera generated $46 million in cash flow during Q4 2024, accumulating to $86 million for the year. This reflects the company's ability to generate cash and maintain financial health. 4. **Signatera Unit Growth**: There was a substantial increase in clinical volumes for Signatera, with growth of approximately 60% compared to Q4 2023. This suggests strong demand for Natera's testing services. 5. **Strategic Advancements**: Natera made strategic advancements, which, along with the improved gross margin, contributed to its financial performance. Overall, Natera's 2024 earnings showcase robust revenue growth, improved profitability, and strategic successes, indicating a strong future outlook for the company.